
NAD+
Compounded NAD+ injection, available if prescribed.
Subject to individual clinical review.
From $169/mo
A GLP-1 therapy, dosed by your provider.
Then $349 every 3 months.
Micro Dose. $349 charged every 3 months.
Payment is taken when you order, before your intake is reviewed. If a provider can’t treat you, you’re refunded in full. Prescription required. Compounded medication is not FDA-approved. Your clinician determines whether treatment is appropriate.
Semaglutide is a GLP-1 receptor agonist: it acts on the same receptor as the body’s own GLP-1 hormone, part of a pathway involved in appetite.

A licensed clinician reviews your health history to decide whether treatment is appropriate for you.
A licensed provider reviews your intake before treatment. If prescribed, your dose is set for you and reviewed as your care progresses.
Support at every stage, so you know what comes next.
Timing and treatment are determined by your clinician. Individual experiences vary.
Once you’re prescribed: three steps, with support along the way.
Delivered to your door
Everything you need arrives in the box, with written instructions and a walkthrough.
Simple weekly routine
A subcutaneous injection once a week, on the same day, following your written instructions.
Ongoing clinical support
Report how you’re responding. Your provider reviews your progress and adjusts your dose if needed.
Personal experiences. Individual results vary.
Treatment-specific, separate from the general FAQ
Responses vary. Your clinician will review your goals, health history, and progress to explain what to expect from your individual treatment.
The most common side effects of Semaglutide are mild-to-moderate gastrointestinal issues, including nausea, diarrhea, vomiting, constipation, and stomach pain, which typically improve within a few weeks.
The treatment shown in this design is a once-weekly subcutaneous injection. If prescribed, follow your clinician’s directions and the instructions supplied with your medication. Ask your clinical team for help if anything is unclear.
Discuss stopping or changing treatment with your clinician. They can help you understand your next steps and plan ongoing care.
No. This is compounded semaglutide. Compounded medications are not FDA-approved and have not undergone FDA review for safety, effectiveness, or quality.
Can’t find the answer you are looking for? Our support team is here to help.
Allow Welm to measure the pages you visit and shopping actions on this site. This optional measurement does not record form answers or payment details.
Your browser privacy preference keeps this measurement off.
You can change this using “Visit measurement” at the bottom of the page. This choice applies to Welm’s visit measurement.